Toshiro Seki

Has grant

Associate Professor of Medicine

Tokai University School of Medicine
Country flagJapan

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Toshiro Seki is an Associate Professor of Medicine at Tokai University School of Medicine in Japan. His research focuses on the immunological aspects of cancer treatment and T cell activation, with recent publications exploring the effects of liposome-encapsulated agents and the role of environmental factors on immune responses. He also investigates pregnancy-related proteins and their implications in various medical conditions.

Recent Grants

Grant: Close

Generation of an adenovirus vector for gene therapy of pituitary tumor

Open Date: 2004-01-01

Close Date: 2006-12-31

Grant: Close

高血圧性臓器障害におけるガス状情報伝達物質(NO.CO)の病態生理学的意義

Open Date: 1999-01-01

Close Date: 1999-12-31

Articles (8)

Coccomyxa subellipsoidea KJ (C-KJ) is a green alga with unique immunoregulatory characteristics. Here, we investigated the mechanism underlying the modification of T cell function by C-KJ components. The water-soluble extract of C-KJ was fractionated into protein (P) and sugar (S) fractions acidic (AS), basic (BS), and neutral (NS). These fractions were used for the treatment of peripheral blood mononuclear cells stimulated with toxic shock syndrome toxin-1. Transcriptome analysis revealed that both P and AS enhanced the expression of the genes encoding metallothionein (MT) family proteins, inflammatory factors, and T helper (Th) 17 cytokine and suppressed that of those encoding Th2 cytokines in stimulated T cells. The kinetics of MT1 and MT2A gene expression showed a transient increase in MT1 and maintenance of MT2A mRNA after T cell stimulation in the presence of AS. The kinetics of Th17-related cytokine secretion in the early period were comparable to those of MT2A mRNA. Furthermore, our findings revealed that static, a STAT-3 inhibitor, significantly suppressed MT2A gene expression. These findings suggest that the expression of MTs is involved in the immune regulatory function of C-KJ components, which is partially regulated by Th17 responses, and may help develop innovative immunoregulatory drugs or functional foods.

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Asako Otomo

Assistant Prof.

Tokai University School of Medicine

JAPAN
View details

Takashi Shiina

Professor

Tokai University

JAPAN
View details

Atsushi Yasuda

Tokai University School of Medicine

JAPAN
View details

Masayuki Oki

Associate professor

Tohoku University Hospital

JAPAN
View details

Yoshie Kametani

Tokai University School of Medicine

JAPAN
View details

Noriaki Hirayama

Visiting Professor

Tokai University

JAPAN
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.